|1|Intake of specific fruits and vegetables in relation to risk of estrogen receptor-negative breast cancer among postmenopausal women. (23532538)
Fung T.T.... Holmes M.D.
|2|Syndecan binding protein (SDCBP) is overexpressed in estrogen receptor negative breast cancers, and is a potential promoter for tumor proliferation. (23533663)
Qian X.L.... Fu L.
|3|Does microenvironment contribute to the etiology of estrogen receptor-negative breast cancer? (23325583)
|4|KISS1R induces invasiveness of estrogen receptor-negative human mammary epithelial and breast cancer cells. (23525242)
Cvetkovic D.... Bhattacharya M.
|5|Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. (23971947)
Hefti M.M.... Beck A.H.
|6|Hydrogen sulfide-releasing aspirin suppresses NF-I_B signaling in estrogen receptor negative breast cancer cells in vitro and in vivo. (22209867)
Chattopadhyay M.... Kashfi K.
|7|Prolactin-induced protein mediates cell invasion and regulates integrin signaling in estrogen receptor-negative breast cancer. (22817771)
Naderi A.... Meyer M.
|8|Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer. (22971289)
Switzer C.H.... Wink D.A.
|9|Coffee consumption modifies risk of estrogen-receptor negative breast cancer. (21569535)
Li J.... Hall P.
|10|Impact of the 21-gene recurrence score assay compared with standard clinicopathologic guidelines in adjuvant therapy selection for node-negative, estrogen receptor-positive breast cancer. (21537874)
Partin J.F.... Mamounas E.P.
|11|MDM2 amplification is an independent prognostic feature of node-negative, estrogen receptor-positive early-stage breast cancer. (21896991)
Choschzick M.... Simon R.
|12|High ACAT1 expression in estrogen receptor negative basal-like breast cancer cells is associated with LDL-induced proliferation. (19851860)
Antalis C.J.... Siddiqui R.A.
|13|Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20. (20065188)
Mamounas E.P.... Wolmark N.
|14|Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and -negative cancers. (20805453)
Bianchini G.... Pusztai L.
|15|CD44posCD49fhiCD133/2hi defines xenograft-initiating cells in estrogen receptor-negative breast cancer. (20484027)
Meyer M.J.... Vonderhaar B.K.
|16|Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers. (21080930)
Tung N.... Richardson A.L.
|17|Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells. (20138962)
Lappano R.... Maggiolini M.
|18|p130Cas substrate domain signaling promotes migration, invasion, and survival of estrogen receptor-negative breast cancer cells. (24367162)
Cunningham-Edmondson A.C.... Hanks S.K.
|19|Leptin-signaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer. (19531256)
Rene Gonzalez R.... Penichet M.L.
|20|MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer. (18790736)
Zhao J.J.... Cheng J.Q.
|21|Estrogen induces estrogen-related receptor alpha gene expression and chromatin structural changes in estrogen receptor (ER)-positive and ER-negative breast cancer cells. (18174157)
Hu P.... Teng C.
|22|Sensitizing estrogen receptor-negative breast cancer cells to tamoxifen with OSU-03012, a novel celecoxib-derived phosphoinositide-dependent protein kinase-1/Akt signaling inhibitor. (18413793)
Weng S.C.... Chen C.S.
|23|Dietary phytoestrogens are not associated with risk of overall breast cancer but diets rich in coumestrol are inversely associated with risk of estrogen receptor and progesterone receptor negative breast tumors in Swedish women. (18424605)
Hedelin M.... Weiderpass E.
|24|Modulation of cell cycles and apoptosis by apicidin in estrogen receptor (ER)-positive and-negative human breast cancer cells. (18313654)
Im J.Y.... Kim H.S.
|25|The CYP1B1_1358_GG genotype is associated with estrogen receptor-negative breast cancer. (17922187)
Justenhoven C.... Brauch H.
|26|Estrogen receptor-negative invasive breast cancer: imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression. (18180338)
Wang Y.... Jeffrey S.S.
|27|Risk estimation of distant metastasis in node-negative, estrogen receptor-positive breast cancer patients using an RT-PCR based prognostic expression signature. (19025599)
Tutt A.... Waldman F.
|28|Human epidermal growth factor receptor 2 status correlates with lymph node involvement in patients with estrogen receptor (ER) negative, but with grade in those with ER-positive early-stage breast cancer suitable for cytotoxic chemotherapy. (17906205)
Bartlett J.M.... Ellis P.
|29|Efficacy of adjuvant chemotherapy according to Prion protein expression in patients with estrogen receptor-negative breast cancer. (17872899)
Meslin F.... Mehrpour M.
|30|Growth inhibition and multidrug resistance-reversing effect of tanshinone I A on human breast cancer cell with estrogen receptor negative]. (17593814)
Jing J.... Wang X.J.
|31|Transgenic introduction of androgen receptor into estrogen-receptor-, progesterone-receptor-, and androgen-receptor-negative breast cancer cells renders them responsive to hormonal manipulation. (16647340)
Garreau J.R.... Pommier S.
|32|Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer. (16331345)
Dignam J.J.... Wickerham D.L.
|33|Interleukin-1alpha protein secretion in breast cancer is associated with poor differentiation and estrogen receptor alpha negativity. (17010072)
Singer C.F.... Kubista E.
|34|Estrogen receptor alpha-negative and progesterone receptor-positive breast cancer: lab error or real entity? (17189985)
Kiani J.... Pervez S.
|35|Diet quality is associated with the risk of estrogen receptor-negative breast cancer in postmenopausal women. (16424129)
Fung T.T.... Holmes M.D.
|36|Selective reduction of estrogen receptor (ER) positive breast cancer occurrence by estrogen receptor modulators supports etiological distinction between ER positive and ER negative breast cancers. (15823713)
|37|The inhibitory effect of flaxseed on the growth and metastasis of estrogen receptor negative human breast cancer xenograftsis attributed to both its lignan and oil components. (15849746)
Wang L.... Thompson L.U.
|38|The synergistic inhibitory effect of 5-aza-2-deoxycytidine and Tamoxifen on estrogen receptor alpha negative breast cancer cell lines in vitro]. (16412295)
Tang B.... Jiang J.
|39|Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trials. (15601638)
Fisher B.... Wolmark N.
|40|Efficacy of Vitamin D compounds to modulate estrogen receptor negative breast cancer growth and invasion. (12711002)
Flanagan L.... Welsh J.
|41|Androgen receptor expression in estrogen receptor-negative breast cancer. Immunohistochemical, clinical, and prognostic associations. (14608899)
Agoff S.N.... Lawton T.J.
|42|Naturally occurring dominant-negative Stat5 suppresses transcriptional activity of estrogen receptors and induces apoptosis in T47D breast cancer cells. (12642867)
Yamashita H.... Fujii Y.
|43|Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancers. (12370825)
Archey W.B.... Arrick B.A.
|44|Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells. (11559546)
Bartucci M.... Surmacz E.
|45|Loss of expression of a 55 kDa nuclear protein (nmt55) in estrogen receptor-negative human breast cancer. (9360842)
Traish A.M.... Moreland R.B.
|46|Invasive capacity and regulation of urokinase-type plasminogen activator in estrogen receptor (ER)-negative MDA-MB-231 human breast cancer cells, and a transfectant (S30) stably expressing ER. (8616826)
Long B.J.... Rose D.P.
|47|Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression. (7538900)
Ferguson A.T.... Davidson N.E.
|48|Why are estrogen-receptor-negative breast cancers more aggressive than the estrogen-receptor-positive breast cancers? (7657526)
Sheikh M.S.... Rochefort H.
|49|Monitoring the chemosensitizing effects of toremifene with flow cytometry in estrogen receptor negative multidrug resistant human breast cancer cells. (1463871)
Baker W.J.... DeGregorio M.W.
|50|Adjuvant CMF for node-negative and estrogen receptor-negative breast cancer patients. (1627434)
Zambetti M.... Silvestrini R.